Browse by Tags

• cholinesterase inhibitor
• mild cognitive impairment

• Is there a horrible secret about dementia drugs?

  Are drug companies hiding some terrible secret from us about their dementia drugs? The signs aren’t good. So far they’ve sponsored seven expensive trials on the drugs, and yet they’ve decided to publish just two of them. Of the five Read More... Posted 14 December 2007 11:13 by Bryan Hubbard | 15 Comments Filed under: galantamine (Razadyne), mild cognitive impairment, cholinesterase inhibitor, donepezil (Aricept), rivastigmine (Exelon)